What You Need to Know.

On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA).He would sell the stock.

Get Teva Pharmaceutical Industries Ltd (TEVA:NYSE) real-time stock quotes, news and financial information from CNBC. This compares to its industry's average Forward P/E of 8.24. Teva Pharmaceutical Industries (NYSE: TEVA) is a well known generic drugmaker that's attracted the attention of a number of well-known investors in the past. TEVA stock trades at a lousy forward price-to-earnings ratio of 4. Dive deeper with interactive charts and top stories of TEVA PHARMACEUTICAL INDUSTRIES LIMITED. Feb 12, 2020 Teva Pharmaceuticals Stock Jumps After Reporting Earnings. ET on August 5, 2020 Press Release • 3 days ago Here's Why Amarin Tumbled 67.7% in the First Half of 2020 The stock has a Forward P/E ratio of 3.19. Over the last 12 months, TEVA's Forward P/E has been as high as 8.43 and as low as 2.50, with a median of 5.84. Shortly after the market open, Teva stock was down 9.1% at $6.42, as broader markets slumped. Teva’s slide follows Tuesday’s nearly 10% drop on opioid litigation news. TEVJF | Complete Teva Pharmaceutical Industries Ltd. stock news by MarketWatch.

Here’s What to Expect. Is Teva Pharmaceuticals Stock a Buy? In May 2015, Teva acquired Auspex Pharmaceuticals, which strengthened its core CNS franchise. At Teva Pharmaceutical Industries Ltd., we promise to treat your data with respect and will not share your information with any third party. The five-year average multiple on TEVA stock is up around 8. Teva to Host Conference Call to Discuss Second Quarter 2020 Financial Results at 8 a.m. View real-time stock prices and stock quotes for a full financial overview. Current and historical p/e ratio for Teva Pharmaceutical Industries (TEVA) from 2006 to 2020. View the latest TEVA stock quote and chart on MSN Money. The Dec 2008 Barr acquisition boosted Teva’s product portfolio significantly. TEVA: Get the latest Teva Pharmaceutical Industries stock price and detailed information including TEVA news, historical charts and realtime prices. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the TEVA is currently sporting a Zacks Rank of #2 (Buy), as well as an A grade for Value. TEVA: Get the latest Teva Pharmaceutical Industries stock price and detailed information including TEVA news, historical charts and realtime prices. TEVA is also sporting a PEG ratio of 0.75. Teva Pharmaceutical Industries (NYSE:TEVA) Downgraded to "Hold" at Zacks Investment Research www.marketbeat.com - June 11 at 12:30 PM Global Focal Adhesion Kinase Market 2020 Share, Industry Size, Growth by Top Key Players, Future Trends, Types and Application and Forecast to 2026 Barron's Online Feb 11, 2020 Teva Reports Earnings Tomorrow. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number.